We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Genetix Launches Second Generation ClonePix System
Product News

Genetix Launches Second Generation ClonePix System

Genetix Launches Second Generation ClonePix System
Product News

Genetix Launches Second Generation ClonePix System


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Genetix Launches Second Generation ClonePix System"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Genetix has announced the launch of the new ClonePix™2 system - the second generation system based on the company’s well-established and successful technology and chemistries for clone screening and selection. The ClonePix 2 system utilizes fluorescence and white light imaging and advanced image analysis capabilities to automatically screen more clones in less time, select cells with optimal expression levels and pick colonies with accuracy and confidence.

The original ClonePix FL systems are used in over one hundred biopharmaceutical organizations and research laboratories to provide faster, more productive workflows than conventional techniques. Often employed to reduce cell line/antibody development times, data from these systems are cited increasingly in scientific literature and at conferences, an indication of acceptance within the industry.

The most frequently applied approach to monitor expression levels takes advantage of specific chemistries developed by Genetix to enable label-free quantification of secreted proteins – a significant advantage when screening and selecting cell lines for production of biotherapeutics, such as monoclonal antibodies.

Dr. Mark Truesdale, Marketing Manager at Genetix, explained the reasoning behind the development of a second generation instrument: “Working closely with our existing customers has enabled us to specify software and hardware enhancements to raise overall performance. Imaging analysis software has been enhanced to improve consistency when ranking clones. A redesign of robotics has reduced the number of plate handling steps, thereby minimizing the risk of colony disturbance or contamination and giving greater picking accuracy. We believe that ClonePix 2 users will experience a smoother, more efficient workflow.”

Advertisement